WARWICK – Biomedical Structures, manufacturer of biomedical textiles for medical devices and other clinical applications, said in a news release it had record-setting capital growth the most recent quarter.
The company, however, did not disclose its investors or its quarterly results.
“2011 has been an exciting year for BMS,” said Biomedical Structures CEO and President John Gray. “Our acquisition of Concordia Medical has enabled us to deliver at improved speed, volume and scope for our medical device customers, and this second quarter is a direct reflection of that added ability.”
BMS said it has experienced a steady increase in demand for its textile development expertise. It has also built out its textile processing capabilities.
“We are looking forward to continuing to build our scientific expertise by expanding our engineering resources and bringing the unique and innovative properties of textiles to our customers as they develop the next generation of medical devices,” Gray said.
Following its acquisition of Concordia’s manufacturing and cleanroom facilities in March, BMS’s production has expanded in volume and scope, and will continue to widen to meet device OEM (original equipment manufacturer) demands, particularly in the development and application of felt scaffolds and other absorbable nonwoven technologies designed for tissues engineering and regrowth applications in a variety of therapeutic sectors.
Biomedical Structures says its expertise is in knitting, braiding, weaving and non-woven technology.
